Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Medshine Discovery synthesizes PARP-1 inhibitors

Feb. 25, 2021

Integral BioSciences divulges Chk1 inhibitors

Feb. 25, 2021

Australian researchers identify potential treatment for fatal brain cancer in children

Feb. 24, 2021

China NMPA accepts IND for JS-111

Feb. 24, 2021

Medshine Discovery synthesizes FGFR and VEGFR dual inhibitors

Feb. 24, 2021

Jinan University synthesizes new EGFR inhibitors

Feb. 24, 2021

BeiGene discloses new PROTACs for cancer

Feb. 24, 2021

Researchers patent new PROTACs

Feb. 24, 2021

Targeting PI3K-driven HER2 expression in colorectal cancer stem cells

Feb. 24, 2021

Pharmaxis initiates phase I/IIa study of PXS-5505 in myelofibrosis

Feb. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...